NCT04428541

Brief Summary

In some symmetrical pediatric ocular pathologies, the treatment is surgical with usually satisfactory postoperative results in visual terms. However, it is often difficult to choose the right moment to operate. The main difficulty is that the child's vision is unknown since the child is still in a preverbal age. The investigators have developed a questionnaire with the aim of quantifying the child's vision so that the decision is most justified. The items of this questionnaire were established based on the literature and were submitted to a panel of experts in ophthalmo-pediatrics. The objective of this study is to determine the internal validity and as far as possible (since there is no equivalent tool) the external validity of the questionnaire developed.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jul 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 9, 2020

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 11, 2020

Completed
1 month until next milestone

Study Start

First participant enrolled

July 16, 2020

Completed
4.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 21, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 21, 2025

Completed
Last Updated

December 10, 2025

Status Verified

December 1, 2025

Enrollment Period

4.8 years

First QC Date

June 9, 2020

Last Update Submit

December 3, 2025

Conditions

Keywords

Eye DiseasesVision DisordersQuestionnaire DesignChildrenInfant

Outcome Measures

Primary Outcomes (1)

  • Measure the internal validity of the questionnaire developed to assess the visual acuity of preverbal children

    Reliability evaluated by Cronbach's alpha coefficient and its 95% confidence interval. unabbreviated scale title : Assessment of Visual Function in Preverbal Children in Bilateral Ocular Pathology Minimum value : 0 Maximum value : 18 Higher scores mean better outcome

    Inclusion

Study Arms (1)

Questionnaire

EXPERIMENTAL

Description : 18 items questionnaire, filled by the parents of the child

Other: Questionnaire for visual function assessment of preverbal children

Interventions

Eligibility Criteria

Age0 Months - 36 Months
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Common to the three groups:
  • Patient aged 0 to 36 months
  • Diagnosis of known ocular pathology
  • For patients targeted by the questionnaire:
  • \- Patient with operable bilateral ocular pathology
  • For negative controls:
  • \- Patient without ocular pathology inducing a decrease in vision
  • For positive controls:
  • Patient with inoperable bilateral ocular pathology
  • Patient without light perception

You may not qualify if:

  • Patient with unilateral ocular pathology
  • Verbal patients (able to express themselves through speech)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fondation A de Rothschild

Paris, 75019, France

Location

MeSH Terms

Conditions

Eye DiseasesVision Disorders

Interventions

Surveys and Questionnaires

Condition Hierarchy (Ancestors)

Sensation DisordersNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Pascal DUREAU, MD

    Fondation A. de Rothschild

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
NETWORK
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 9, 2020

First Posted

June 11, 2020

Study Start

July 16, 2020

Primary Completion

May 21, 2025

Study Completion

May 21, 2025

Last Updated

December 10, 2025

Record last verified: 2025-12

Locations